Gwi R. Kim

Gwangju, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

MicroRNA-212-5p and its target PAFAH1B2 suppress vascular proliferation and contraction via the downregulation of RhoA.

MicroRNA-212-5p and its target PAFAH1B2 suppress vascular proliferation and contraction via the downregulation of RhoA.

Journal: PloS one
Published: October 28, 2020

HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.

HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 19, 2020

Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension.

Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension.

Journal: PloS one
Published: November 20, 2018

Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure.

Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure.

Journal: Scientific reports
Published: November 06, 2018

Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice.

Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice.

Journal: Clinical hypertension
Published: October 30, 2018

Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension.

Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension.

Journal: Journal of cellular and molecular medicine
Published: August 08, 2018

Dendropanax morbifera Prevents Cardiomyocyte Hypertrophy by Inhibiting the Sp1/GATA4 Pathway.

Dendropanax morbifera Prevents Cardiomyocyte Hypertrophy by Inhibiting the Sp1/GATA4 Pathway.

Journal: The American journal of Chinese medicine
Published: July 11, 2018

Gentisic acid attenuates pressure overload-induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway.

Gentisic acid attenuates pressure overload-induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway.

Journal: Journal of cellular and molecular medicine
Published: May 24, 2018

Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure.

Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure.

Journal: Scientific reports
Published: January 26, 2018

Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.

Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 29, 2017

Gallic acid attenuates pulmonary fibrosis in a mouse model of transverse aortic contraction-induced heart failure.

Gallic acid attenuates pulmonary fibrosis in a mouse model of transverse aortic contraction-induced heart failure.

Journal: Vascular pharmacology
Published: August 23, 2017

Gallic acid attenuates calcium calmodulin-dependent kinase II-induced apoptosis in spontaneously hypertensive rats.

Gallic acid attenuates calcium calmodulin-dependent kinase II-induced apoptosis in spontaneously hypertensive rats.

Journal: Journal of cellular and molecular medicine
Published: June 02, 2017
Showing 1-12 of 23

Last Updated: 09/26/2026